NCT07648953
Microvideos for Improving HPV Vaccination Among Childhood Cancer Survivors
Recruiting
NAAges 18–26InterventionalPreventionUniversity of UtahInvestigator-initiated
~55 participants
Updated 2026-06-15 on ClinicalTrials.gov
What's tested:Microvideos: HPV Vaccination Education
At a glance
Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility of Microvideo education
Measured over up to 4 weeks
Conditions
Where it's being run
1 sites across 1 statesUtah1
Study leadership
- Echo Warner, MPH, PhD, SB · PRINCIPAL_INVESTIGATOR · Huntsman Cancer Institute
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Eligible participants include cancer survivors who are currently ages 18-26 years and who were diagnosed with childhood cancer (ages 0-26 at diagnosis) in the past ten years.
Currently use Facebook or willing to create a Facebook account to use for the duration of the study.
At the time of enrollment, have not completed all recommended doses of the HPV vaccine.
Exclusion
Unable to speak and understand English.
Participants who take part in the Aim 1 focus groups will be ineligible for the Aim 2 social media group.
Participants who are fully vaccinated for HPV will be ineligible as the goal of Aim 2 is to evaluate the feasibility of the social media campaign for improving vaccine intention among HPV unvaccinated individuals.
What this trial measures
- Feasibility of Microvideo educationup to 4 weeks
Feasibility will be defined as ≥80% of participants completing the intervention and study surveys.